Latest news about Mercury Laboratories
Mercury Laboratories
782.00
+22.35(+2.94%)
Company Performance:
View Company Insights1D+2.94%
1M+1.56%
6M-7.55%
1Y-7.63%
5Y+3.10%
More news about Mercury Laboratories
04Nov 25
Mercury Laboratories Appoints Seema Salvi as Head of Injectable Production Department
Mercury Laboratories Limited has appointed Ms. Seema Salvi as the Head of the Injectable Production Department, effective November 04, 2025. Ms. Salvi, 49, brings over 26 years of experience in injection production to her new role. She holds a Bachelor's degree in Pharmacy and has previously worked with Harson Laboratories India Pvt. Ltd. and Crescent Labs Pvt Ltd. This full-time appointment to the senior management team aims to strengthen the company's production capabilities in the injectable drugs segment.
13Aug 25
Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth
Mercury Laboratories Limited reported strong financial results for the recent quarter. Total revenue increased by 8.9% to ₹18.32 crore, while net profit after tax surged by 183.3% to ₹96.76 lakh. The EBITDA margin expanded to 13.9% from 10.5%. Revenue from operations grew by 8.7% to ₹18.14 crore. The company's performance was attributed to higher operating leverage, improved cost management, and a favorable product mix. Despite increases in material costs and employee expenses, effective cost control measures led to a 9.4% decrease in other expenses to ₹4.29 crore.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Dr Reddys Laboratories
Lupin
Mankind Pharma
Zydus Life Science
Aurobindo Pharma
Laurus Labs
1,880.80
(+0.94%)
6,940.00
(+0.27%)
4,430.00
(+0.59%)
1,436.30
(-0.03%)
1,319.80
(+1.24%)
2,291.50
(+1.47%)
2,504.80
(+1.73%)
1,004.05
(+1.25%)
1,512.50
(+0.11%)
1,319.70
(+0.32%)
Get More Market Insights with
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
